Skip to main content

Table 2 Multivariate analysis for OS and basal patient and disease characteristics

From: Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center

 

HR

95% CI for HR

P value

Inferior

Superior

Triple negative

2.334

1.215

4.481

0.011

> 2 organs involvement

2.272

1.19

4.274

0.013

Age (< 70 years old)

2.354

1.070

5.180

0.033

Visceral metastases

2.35

0.236

1.259

0.155

Taxane-refractary

0.977

0.566

1.688

0.934

Grade 3–4 toxicities

1.723

0.966

3.072

0.065

  1. Abbreviations: OS overall survival, HR hazard ratio, CI confidence interval